Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapse in Schizophrenia”

61 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 61 results

Not applicableStudy completedNCT05480046
What this trial is testing

Non-interventional Study of Risperidone ISM® in Schizophrenia Patients Hospitalised Due to a Relapse

Who this might be right for
Schizophrenia
Rovi Pharmaceuticals Laboratories 275
Not applicableUnknownNCT02221635
What this trial is testing

Efficacy of Repetitive Transcranial Magnetic Stimulation in the Prevention of Relapse of Schizoaffective

Who this might be right for
Schizoaffective Disorder
Xijing Hospital 540
Testing effectiveness (Phase 2)Study completedNCT01214005
What this trial is testing

Smoking Abstinence and Lapse Effects in Smokers With Schizophrenia and Controls

Who this might be right for
Tobacco Use DisorderSchizophrenia
Brown University 60
Post-approval studies (Phase 4)Study completedNCT00848432
What this trial is testing

Risperidone Maintenance Treatment in Schizophrenia

Who this might be right for
Schizophrenia
Capital Medical University 404
Post-approval studies (Phase 4)Not Yet RecruitingNCT06546475
What this trial is testing

A Pilot Trial of Tapering Antipsychotics for Patients in Remitted Psychosis Co-administering With N-Acetylcysteine

Who this might be right for
Psychosis
National Taiwan University Hospital 20
Not applicableUnknownNCT03000985
What this trial is testing

Evaluation of a Psychoeducation Program for Families Caregivers of Schizophrenic Patients : Randomized Study in Two Arms

Who this might be right for
SchizophreniaMental DisorderEducational Problems+5 more
Centre Hospitalier Charles Perrens, Bordeaux 60
Not applicableStudy completedNCT01202617
What this trial is testing

Seroquel XR in the Long Term Treatment of Schizophrenia

Who this might be right for
Relapse in Schizophrenia
AstraZeneca 1,606
Not applicableStudy completedNCT03019887
What this trial is testing

Correlation Between Cognitive Function and Relapse of Schizophrenia Regarding Dose Reduction

Who this might be right for
Schizophrenia Relapse
Juntendo University 139
Not applicableUnknownNCT01936220
What this trial is testing

Relapse Prevention in First Episode Schizophrenia: a 5 Year Trial

Who this might be right for
Schizophrenia
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 200
Large-scale testing (Phase 3)Study completedNCT00150176
What this trial is testing

To Determine Long Term Efficacy and Safety of Asenapine in Schizophrenic Patient Population (A7501012)(COMPLETED)(P05770)

Who this might be right for
Schizophrenia
Organon and Co 831
Large-scale testing (Phase 3)Study completedNCT01291511
What this trial is testing

Relapse Prevention Study in Patients With Schizophrenia

Who this might be right for
Schizophrenia
Vanda Pharmaceuticals 635
Large-scale testing (Phase 3)Looking for participantsNCT07686263
What this trial is testing

Relapse Prevention Trial Evaluating KarXT Treatment in Schizophrenia

Who this might be right for
Schizophrenia
Karuna Therapeutics, Inc., a Bristol Myers Squibb company 472
Not applicableStudy completedNCT00358852
What this trial is testing

Scale Validation Study for Prediction of Relapse and Short Term Rehospitalization in Patients With Schizophrenia

Who this might be right for
Schizophrenia
Janssen-Cilag, S.A. 2,339
Large-scale testing (Phase 3)Ended earlyNCT03593213
What this trial is testing

Clinical Trial Evaluating the Efficacy, Safety, and Tolerability of Cariprazine in a Dose-Reduction Paradigm in the Prevention of Relapse in Participants With Schizophrenia

Who this might be right for
Schizophrenia
AbbVie 587
Not applicableUnknownNCT03248180
What this trial is testing

Guided Dose Reduction of Antipsychotic in Patients With Psychosis in Remitted States

Who this might be right for
PsychosisRemission
National Taiwan University Hospital 160
Large-scale testing (Phase 3)Study completedNCT01662310
What this trial is testing

An Efficacy Study of Paliperidone for the Prevention of Relapse in Participants With Schizophrenia

Who this might be right for
Schizophrenia
Janssen Research & Development, LLC 201
Not applicableStudy completedNCT05986409
What this trial is testing

Indoor Artificial Light at Night and the Relapse Risk of Schizophrenia

Who this might be right for
Schizophrenia RelapseLight Pollution
Weizhuo Yi 50
Not applicableUnknownNCT04230590
What this trial is testing

Health Outcomes Via Positive Engagement in Schizophrenia

Who this might be right for
Schizophrenia Spectrum Disorders
Institute of Mental Health, Singapore 100
Large-scale testing (Phase 3)Study completedNCT01193153
What this trial is testing

Evaluate the Efficacy of Paliperidone Palmitate in the Prevention of Relapse of the Symptoms of Schizoaffective Disorder

Who this might be right for
Schizoaffective Disorder
Janssen Scientific Affairs, LLC 667
Large-scale testing (Phase 3)Study completedNCT00228462
What this trial is testing

Relapse Prevention, RoW: Study to Evaluate Prevention of Relapse in Patients in Stable Chronic Schizophrenia Receiving Either Seroquel or Placebo

Who this might be right for
Schizophrenia
AstraZeneca 197
Next Page